Pegfilgrastim Package Insert

Giving Yourself An Injection Of Filgrastim (Neupogen®) Or ...
Pegfilgrastim (Neulasta®) With a Name – Make sure the medication name on the package or syringe label matches what your doctor prescribed for you. 14. Insert the needle into your skin in one quick motion at a 90-degree (straight up ... Access Full Source

HIGHLIGHTS OF PRESCRIBING INFORMATION With A Fluoropyrimidine ...
3 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Melanoma KEYTRUDA®(pembrolizumab) is indicated for the treatment of patients with unresectable or metastatic melanoma [see Clinical Studies (14.1)]. 1.2 Non-Small Cell Lung Cancer ... Fetch This Document

Therapeutic Class Overview Colony-Stimulating Factors
Pegfilgrastim are FDA-approved to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive chemotherapy ... Document Viewer

Neulastim - Medsafe
NEULASTIM solution for injection contains the active ingredient pegfilgrastim. Using gene technology, pegfilgrastim is produced in a specific type of bacteria, called . E. coli. Pegfilgrastim is a longacting form of - recombinant human Granulocyte Colony Stimulating Factor (G-CSF). ... Fetch Content

Neupogen (filgrastim), Granix (tbo-filgrastim), Nivestym ...
Filgrastim to patients with a history of serious allergic reactions to pegfilgrastim or filgrastim (1-4). Severe sickle cell crises can occur in patients with sickle cell disorders receiving filgrastim. Severe and sometimes fatal sickle cell crises can occur in patients with sickle cell disorders receiving ... Fetch Full Source

D (S) Neulasta (pegfilgrastim)
Neulasta [package insert]. Thousand Oaks, CA; Amgen Inc; December 2016. Accessed January 2017. 2. Referenced with permission from the NCCN Drugs & Biologics Compendium (NCCN Compendium®) pegfilgrastim. National Comprehensive Cancer Network, 2016. The NCCN Compendium® is a derivative work of the NCCN Guidelines®. NATIONAL COMPREHENSIVE ... Retrieve Document

HIGHLIGHTS OF PRESCRIBING INFORMATION - Genentech
(trastuzumab) for injection, for intravenous use Initial U.S. Approval: 1998 . WARNING: CARDIOMYOPATHY, INFUSION REACTIONS, EMBRYO-FETAL TOXICITY, and PULMONARY TOXICITY . See full prescribing information for complete boxed warni ng . ... Fetch Full Source

Colony Stimulating Factors: Neulasta® (pegfilgrastim)
1. Neulasta [package insert]. Thousand Oaks, CA; Amgen Inc; November 2015. Accessed April 2016. 2. Referenced with permission from the NCCN Drugs & Biologics Compendium (NCCN Compendium®) pegfilgrastim. National Comprehensive Cancer Network, 2016. The NCCN Compendium® is a derivative work of the NCCN Guidelines®. NATIONAL ... Doc Viewer

HIGHLIGHTS OF PRESCRIBING INFORMATION Do Not Administer To ...
Noxafil delayed-release tablets and Noxafil oral suspension Patients who have severe diarrhea or vomiting should be monitored closely for breakthrough fungal infectionswhen receiving Noxafil delayed-release tablets or oral suspension. ... Fetch Document

HIGHLIGHTS OF PRESCRIBING INFORMATION Interstitial Lung ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use HYCAMTIN FOR INJECTION safely and effectively. ... Retrieve Content

Neulasta CC - Arise Health Plan
Pegfilgrastim injection (Neulasta®) Date reviewed: 12/9/2009. Description. Like filgrastim (Neupogen), pegfilgrastim is a human granulocyte colony stimulating factor (G-CSF) which acts on hematopoietic cells and has various functions such as stimulating the production of neutrophils within the bone marrow. ... Retrieve Doc

HIGHLIGHTS OF PRESCRIBING INFORMATION Hypotension, Throat ...
FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE LEXISCAN® (regadenoson) injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress. ... View Full Source

HIGHLIGHTS OF PRESCRIBING INFORMATION First-Line Non Squamous ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AVASTIN safely and effectively. See full prescribing information for ... Retrieve Here

Filgrastim, Lenograstim, Nartograstim, Pegfilgrastim
Concluded that revision of the package insert was necessary. The number of reported adverse reactions and fatal cases in the last 3 fiscal years in Japan 1. N/A 2. a. A total of 4 cases associated with anaphylaxis has been reported (including a case for which a causal relationship to the product could not be ruled out). No fatality has been ... Access Full Source

Lestaurtinib - Wikipedia
Lestaurtinib (rINN, codenamed CEP-701) is a tyrosine kinase inhibitor structurally related to staurosporine. This semisynthetic derivative of the indolocarbazole K252a was investigated by Cephalon as a treatment for various types of cancer. ... Read Article

Pharmacy Medical Necessity Guidelines: Pegfilgrastim Products ...
Fulphila (pegfilgrastim-jmdb) is a biosimilar to Neulasta (pegfilgrastim) indicated to decrease the incidence of infection, as manifested by FN, in patients with non-myeloid malignancies receiving Fulphila (pegfilgrastim-jmdb) [package insert]. Zurich, Switzerland: Mylan GmbH; June 2018. 5 ... View Doc

Package Leaflet: Information For The User Neulasta 6 Mg ...
Package leaflet: Information for the user Neulasta 6 mg solution for injection pegfilgrastim Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. ... View Document

NEULASTA (pegfilgrastim), FULPHILA (pegfilgrastim-jmdb ...
Neulasta (pegfilgrastim) and Fulphila (pegfilgrastim-jmdb) are granulocyte colony-stimulating factors (G-CSF) that act on hematopoietic cells by binding to specific cell surface receptors, thereby stimulating proliferation, differentiation, commitment, and end cell functional activation. ... Retrieve Doc